ArticleBiogerontology2026
Lifespan stops at death, but when does healthspan stop?
Article in Biogerontology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
8 citing papers in PubMed.
- Mitochondrial homeodynamics in ageing: mechanisms, resilience, and interventions.Biogerontology · 2026Review
- Stress biology and metabolic ageing in older adults during prolonged crises: Ukraine as an example.Biogerontology · 2026Review
- When is health adequate for older adults? Optimal standards, patient-defined thresholds, and the weight of inequality.Biogerontology · 2026Review
- Genetic evidence links hypertension to accelerated brain aging.Biogerontology · 2026Article
- Diets Rich inNutrients · 2026Article
- A multi-ingredient food supplement slows age-dependent decline of mobility and influences gene expression in C. elegans.Biogerontology · 2026Article
- Dendrobium officinale leaf extract extends the mean lifespan in Caenorhabditis elegans via the DAF-16/SOD-3 axis.Biogerontology · 2026Article
- Aging modulatory effects of a decoction in Drosophila and C. elegans: mechanistic insights through NMR-based metabolomics.Biogerontology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This editorial delineates the conceptual distinctions among lifespan, longevity, and healthspan in biogerontology. Lifespan is defined as the chronological duration from birth to biological death. Longevity refers to the capacity for survival beyond the species-typical average and is best understood probabilistically rather than as a predetermined limit. Healthspan, by contrast, lacks a uniform definition but is most commonly described as the period of life free from major chronic disease and significant functional decline. Healthspan is often considered to end with the onset of clinically significant impairment(s) that compromise physical or mental independence, irrespective of chronological age. Yet survival often persists beyond this point, highlighting the roles of medical, physiological, technological, and psychosocial compensations that enable continued existence despite markedly reduced health. Therefore, framing health through the lens of homeodynamic space positions it as the ability to sustain physical and mental independence adequately. Greater conceptual clarity is essential to enhance research alignment, improve cross-study comparability, and guide interventions that extend not merely chronological lifespan, but meaningful, context-sensitive healthy lifespan, even in the presence of disease(s). Biogerontology invites original research, review, and perspective articles addressing these issues.
Indexed as
Identifiers
41903027What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.